| GTO ID | GTC2419 |
| Trial ID | NCT04503980 |
| Disease | Colorectal Cancer | Ovarian Cancer |
| Altered gene | MESO |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | αPD1-MSLN-CAR-T cells |
| Phase | Early_Phase1 |
| Recruitment status | Unknown |
| Title | αPD1-MSLN-CAR T Cells for the Treatment of MSLN-positive Advanced Solid Tumors |
| Year | 2020 |
| Country | China |
| Company sponsor | Shanghai Cell Therapy Group Co., Ltd |
| Other ID(s) | BZDS1901 |
| Cohort 1 | |||||||||||||
|
|||||||||||||